Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HMG box transcription factor BBX (BBX) is a member of the HMG-box superfamily of DNA-binding proteins, which contains a single HMG (High Mobility Group) box domain[3][5]. BBX acts as a sequence-specific transcription factor, binding double-stranded DNA and regulating transcription by RNA polymerase II[1][2][5]. It is necessary for proper cell cycle progression from G1 to S phase[4]. BBX is predominantly nuclear and has predicted roles in chromatin organization and gene transcription. In mammalian systems, it functions as a regulatory node in forebrain development and may be involved in neurogenic patterning; its expression is notably high in the cortex and hippocampus, suggesting a role in central nervous system development[2]. Variations in the BBX gene region have been associated with risk for Alzheimer’s disease, indicating a potential role in neurodegeneration[1]. The precise mechanisms, interacting partners, and therapeutic or diagnostic utility of BBX in human disease are still largely unknown, and there are no drugs currently known to directly target BBX[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HMG box transcription factor BBX (BBX).